GSK plc (GSK) Stock Overview
Explore GSK plc’s financial performance, market position, analyst ratings, and future outlook.
GSK plc (GSK)
Key Financials
Key Financials
Market Cap
93.4B
P/E Ratio
14.64
EPS (TTM)
$4.63
ROE
0.24%
GSK Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of GSK plc (NYSE: GSK) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, GSK plc's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of GSK on the NYSE shows an RSI of 31.99, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $56.98 for the NYSE listing.
Key metrics behind GSK plc's NYSE-traded stock include a P/E ratio of 14.64 and a market capitalization of 93.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of GSK on the NYSE.